Piramal Pharma Limited — Important, 23-10-2024: Financial Result Updates

Piramal Pharma Limited reported its unaudited financial results for the quarter and half-year ending September 30, 2024. Total income increased to ₹1,390.77 crores, with a profit before tax of ₹275.71 crores. The profit after tax stood at ₹210.06 crores. Significant cash flow activities included net cash used in investing activities of ₹479.26 crores, while cash equivalents decreased by ₹111.42 crores. The Board approved these results during its recent meeting.